Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial

Na+-H+ Exchanger Inhibition

A New Antihypertrophic Tool

Horacio E. Cingolani, María Cristina Camilión de Hurtado
Download PDF
https://doi.org/10.1161/01.RES.0000016836.24179.AE
Circulation Research. 2002;90:751-753
Originally published April 19, 2002
Horacio E. Cingolani
From the Centro de Investigaciones Cardiovasculares, Universidad Nacional de La Plata, Argentina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Cristina Camilión de Hurtado
From the Centro de Investigaciones Cardiovasculares, Universidad Nacional de La Plata, Argentina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics

Jump to

  • Article
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading
  • Na+-H+ exchanger
  • cardiac hypertrophy
  • NHE1 inhibitors

Cardiac hypertrophy (CH) is a major risk factor for cardiac death and commonly precedes the development of heart failure (HF). This is motivating the search for novel pharmacological strategies to prevent the development and/or regress CH. Although the signaling pathways leading to myocardial hypertrophy are complex, one important set of pathways involves the mitogen-activated protein kinases (MAPKs).1 MAPKs phosphorylate numerous substrates, including nuclear transcription factors that activate the expression of different genes. The Na+-H+ exchanger (NHE) is a common downstream effector of this cascade2–4⇓⇓ and has been implicated in different models of hypertrophy, such as “hypertensive” myocardium, aortic constriction-induced hypertrophy, and postinfarction myocardial hypertrophy.5–8⇓⇓⇓ Interestingly, stretch-induced hypertrophy of cultured neonatal cardiomyocytes is also accompanied by an increase in MAPK activity6,8⇓ and NHE activation. Furthermore, stretch-induced MAPK stimulation is partially prevented by inhibition of NHE activity.6

The article published in this issue of Circulation Research by Engelhardt et al9 reports another example of a link between NHE activity and cellular growth, employing a different experimental model of CH induced by overexpression of β1-adrenergic receptors in transgenic mice. CH, fibrosis, and failure induced by this model were prevented by NHE inhibition. The overstimulation of β1-adrenergic receptors with isoproterenol is perhaps a similar experimental model of hypertrophy that has been extensively studied before10–13⇓⇓⇓ and reported to be mediated by p41/p42-MAPK activation.13 Karmazyn’s group7 reported that the inhibition of NHE activity attenuated the hypertrophy that follows myocardial infarction. Camilión de Hurtado et al14 recently reported that chronic NHE blockade in vivo induces regression of CH in spontaneously hypertensive rats (SHR) without a significant decrease in arterial pressure. The in vivo blockade of NHE also decreases the cellular proliferation detected in vessels from diabetic rats.15 Taken together, these findings provide compelling evidence of a common role played by NHE in different models of myocardial hypertrophy.

Which would be the relationship between NHE activity and myocardial hypertrophy? Perhaps the most convincing demonstration of a signaling role for NHE activation in cellular growth is found in sea urchin eggs, where fertilization is followed by NHE activation, and cellular growth is precluded if NHE activation is prevented.16 Because NHE exchanges intracellular H+ for extracellular Na+ in a one-by-one stoichiometry, the intracellular ionic changes resulting from its activation will be a decrease in [H+]i and an increase in [Na+]i. However, whereas the activation of NHE may result in nonsignificant changes in pHi (under physiological conditions where the bicarbonate-dependent mechanisms are active),17–19⇓⇓ the increase in [Na+]i is always detected.20 This rise in [Na+]i might be responsible for an increase in [Ca2+]i levels mediated by Na+-Ca2+ exchange (NCX). The increase in [Ca2+]i is recognized as a cell growth signal.21 NHE can carry ≈50% of the Na+ entering the cells.22 We should, therefore, learn to think more of increases of [Na+]i than in increases of pHi when NHE is activated by “growth factors.” Conversely, blockade of NHE activity will promote the decrease of [Na+]i levels.

Recently, a new factor has been identified to contribute to the NHE hyperactivity-hypertrophy relationship: the anion exchanger (AE).23 Some isoforms of the AE are upregulated in the hypertrophied myocardium.24 This exchanger is, even at steady pHi, continuously loading the cell with acid.25 This acid load is balanced by other acid extruder mechanisms, and under normal conditions, pHi is kept within normal limits. AE hyperactivity, by increasing [H+]i, will stimulate the NHE leading to the increase of [Na+]i. Interestingly, β1-adrenergic receptor stimulation enhances AE activity.26 It is possible that isoproterenol (or overexpression of β1 receptors), through AE stimulation, increases [H+]i, thereby causing NHE activation. The possible linkage between NHE and other ionic membrane transport mechanisms is depicted in the Figure.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

[Ca2+]i is known to be a hypertrophic signal either acting through kinases such as PKC and/or the Ca2+/calmodulin-activated phosphatase, calcineurin. [Ca2+]i is modified by [Na+]i through modulation of NCX function. Because ≈50% of Na+ entry is due to NHE activity, we should expect a rise of [Na+]i when NHE activity increases and, conversely, a decrease in [Na+]i when it decreases. NHE activity can be increased by several interventions. β1-Receptor stimulation, which itself does not increase NHE function, can through the activation of AE activity induce NHE stimulation leading to the rise of [Na+]i and, consequently, of [Ca2+]i.

It has been previously demonstrated that [Na+]i increases in hypertrophied myocardium.27 Furthermore, in isolated myocytes and vascular smooth muscle cells, Na+ has a direct effect of increasing protein synthesis and decreasing protein degradation.28 Epidemiological and basic studies support the notion that Na+ is an independent factor for the development of salt-induced CH.29,30⇓ Frohlich and colleagues reported that a high Na+ diet increased not only cardiac enlargement in SHR but also cardiac mass in normotensive rats without detectable change of arterial pressure.31 Therefore, given the fact that NHE is a pathway for Na+ entry, its pharmacological blockade appears to be an intervention capable of reducing Na+ influx.

An increased activity of the NHE has been detected in HF32 and cariporide has been shown to have antiapoptotic effect that, as proposed by Humpreys et al,33 could be of help in HF. It is not evident to us why, in the article by Engelhardt et al,9 the regression of hypertrophy was accompanied by normalization (through a translational mechanism) of NHE activity after the blockade. This finding deserves further investigation but it is interesting that the regression of CH after antihypertensive treatment is also accompanied by normalization (through a posttranslational mechanism) of NHE activity in SHR.34

Engelhardt et al9 also reported fibrosis in accompanying CH in the mice overexpressing β1-adrenergic receptors. However, neither fibrosis nor increases in myocardial stiffness has been detected in previous experiments10–13⇓⇓⇓ in which hypertrophy is induced by isoproterenol. The possibility of “reparative fibrosis” instead of “reactive fibrosis” that characterizes the hypertensive hypertrophy was raised by the authors. Further studies about possible changes in diastolic compliance, collagen cross-linking, and/or accumulation of different collagen subtypes35 will be required to properly characterize this model of hypertrophy.

Footnotes

  • The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.

References

  1. ↵
    Clerck A, Sugden PH. Activation of protein kinase cascades in the heart by hypertrophic G protein–coupled receptor agonists. Am J Cardiol. 1999; 83: 64H–69H.
    OpenUrlPubMed
  2. ↵
    Bianchini L, L’Allemain G, Pouysségur J. The p42/p44 mitogen-activated protein kinase cascade is determinant in mediating activation of the Na+-H+ exchanger (NHE1 isoform) in response to growth factors. J Biol Chem. 1997; 272: 271–279.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Moor AN, Fliegel L. Protein kinase-mediated regulation of the Na+-H+ exchange in the rat myocardium by mitogen-activated protein kinase-dependent pathways. J Biol Chem. 1999; 274: 22985–22992.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Snabaitis AK, Yokoyama H, Avkiran M. Roles of mitogen-activated protein kinases and protein kinase C in α1A-adrenoceptor-mediated stimulation of the sarcolemmal Na+-H+ exchanger. Circ Res. 2000; 86: 214–222.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Pérez NG, Alvarez BV, Camilión de Hurtado MC, Cingolani HE. pHi regulation in myocardium of the spontaneously hypertensive rat: compensated enhanced activity of the Na+-H+ exchanger. Circ Res. 1995; 77: 1192–1120.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Takewaki S, Kuro-o M, Hiroi Y, Yamazaki T, Noguchi T, Miyagishi A, Nakahara K, Aikawa M, Manabe I, Yazaki Y, et al. Activation of Na+-H+ antiporter (NHE-1) gene expression during growth, hypertrophy and proliferation of the rabbit cardiovascular system. J Mol Cell Cardiol. 1995; 27: 729–742.
    OpenUrlCrossRefPubMed
  7. ↵
    Yoshida H, Karmazyn M. Na+-H+ exchange inhibition attenuates hypertrophy and heart failure in 1-wk postinfarction rat myocardium. Am J Physiol Heart Circ Physiol. 2000; 278: H300–H304.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Yamazaki T, Komuro I, Kudoh S, Zou Y, Nagai R, Aikawa R, Uozumi H, Yazaki Y. Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy. Circ Res. 1998; 82: 430–437.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Engelhardt S, Hein L, Keller U, Klämbt K, Lohse MJ. Inhibition of Na+-H+ exchange prevents hypertrophy, fibrosis, and heart failure in β1-adrenergic receptor transgenic mice. Circ Res. 2002; 90: 814–819.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Nagano M, Higaki J, Nakamura F, Higashimori Koichi, Nagano N, Mikami H, Ogihara T. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Hypertension. 1992; 19: 708–712.
    OpenUrlPubMed
  11. ↵
    Golomb E, Abassi ZA, Cuda G, Stylianou M, Panchal VR, Trachewsky D, Keiser HR. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Am J Physiol Heart Circ Physiol. 1994; 267: H1496–H1506.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Leenen FHH, White R, Yuan B. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Am J Physiol Heart Circ Physiol. 2001; 281: H2410–H2416.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Zou Y, Komuro I, Yamazaki T, Kudoh S, Uozumi H, Kadowaki T, Yazaki Y. Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy. J Biol Chem. 1999; 274: 9760–9770.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Camilión de Hurtado MC, Portiansky EL, Pérez NG, Rebolledo OR, Cingolani HE. Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na+-H+ exchanger. Cardiovasc Res. In press.
  15. ↵
    Jandeleit-Dahm K, Hannan KM, Farrelly CA, Allen TJ, Rumble JR, Gilbert RE, Cooper ME, Little PJ. Diabetes-induced vascular hypertrophy is accompanied by activation of Na+-H+ exchange and prevented by Na+-H+ exchange inhibition. Circ Res. 2000; 87: 1133–1149.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Moolenaar WH, Bierman AJ, de Laat SW. Effects of growth factors on Na+-H+ exchange.In: Grinstein S, ed. Na+-H+ Exchange. Boca Raton, Fla: CRC Press Inc; 1998: 227–234.
  17. ↵
    Boron WF, Boyarski G, Ganz M. Regulation of intracellular pH in renal mesangial cells. Ann N Y Acad Sci. 1989; 574: 321–332.
    OpenUrlPubMed
  18. ↵
    Camilión de Hurtado MC, Alvarez BV, Pérez NG, Ennis IL, Cingolani HE. Angiotensin II activates Na+-independent Cl−-HCO3− exchange in ventricular myocardium. Circ Res. 1998; 82: 473–481.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Camilión de Hurtado MC, Alvarez BV, Ennis IL, Cingolani HE. Stimulation of myocardial Na+-independent Cl−-HCO3− exchanger by angiotensin II is mediated by endogenous endothelin. Circ Res. 2000; 86: 622–627.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Pérez NG, Camilión de Hurtado MC, Cingolani HE. Reverse mode of the Na+-Ca2+ exchange following myocardial stretch: underlying mechanism of the slow force response. Circ Res. 2001; 88: 376–782.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Marbán E, Koretsune Y. Cell calcium, oncogenes, and hypertrophy. Hypertension. 1990; 15: 652–658.
    OpenUrlPubMed
  22. ↵
    Frelin C, Vigne P, Lazdunski M. The role of the Na+-H+ exchange system in cardiac cells in relation to the control of the internal Na+ concentration. J Biol Chem. 1984; 259: 8880–8885.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Alvarez BV, Fujinaga J, Casey JR. Molecular basis for angiotensin II–induced increase of chloride/bicarbonate exchange in the myocardium. Circ Res. 2001; 89: 1246–1253.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Chiappe de Cingolani G, Morgan P, Mundiña-Weilenmann C, Casey J, Fujinaga J, Camilión de Hurtado MC, Cingolani HE. Hyperactivity and altered mRNA isoform expression of the Cl−/HCO3− anion-exchanger in the hypertrophied myocardium. Cardiov Res. 2001; 51: 71–79.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Leem CH, Lagadic-Gossman D, Vaughan-Jones RD. Characterization of intracellular pH regulation in the guinea-pig ventricular myocyte. J Physiol. 1999; 517: 159–180.
    OpenUrlCrossRefPubMed
  26. ↵
    Vassort G, Pucéat M, Désilets M. Chloride dependence of pH modulation by β-adrenergic agonist in rat cardiomyocytes. Circ Res. 1994; 75: 862–869.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Gray PR, McIntyre H, Sheridan DS, Fry CH. Intracellular sodium and contractile function in hypertrophied human and guinea-pig myocardium. Pflügers Arch. 2001; 442: 117–123.
    OpenUrlCrossRefPubMed
  28. ↵
    Gu JW, Anand V, Shek EW, Moore MC, Brady AL, Kelly WC, Adair TH. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension. 1998; 31: 1083–1087.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Du Calair G, Ribstein J, Daures J-P, Minran A. Sodium and left ventricular mass in untreated hypertensive and normotensive subjects. Am J Physiol. 1992; 263: H177–H181.
    OpenUrlPubMed
  30. ↵
    Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation. 1988; 78: 951–956.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Frohlich ED, Apstein C, Chobanian A, Devereux R, Dustan H, Dzau V, Fauad-Tarazi F, Horan M, Marcus M, Massie B, Pfeffer M, Re R, Roccella E, Savage D, Shub C. The heart in hypertension. N Engl J Med. 1992; 327: 998–1008.
    OpenUrlCrossRefPubMed
  32. ↵
    Yokoyama H, Gunasegaram S, Harding SE, Avkiran M. Sarcolemmal Na+-H+ exchanger activity and expression in human ventricular myocardium. J Am Coll Cardiol. 2000; 36: 534–540.
    OpenUrlCrossRefPubMed
  33. ↵
    Humpreys RA, Haist JV, Chakrabarti S, Feng Q, Arnold JM, Karmazyn M. Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion. Am J Physiol. 1999; 276: H749–H757.
    OpenUrlPubMed
  34. ↵
    Ennis IL, Alvarez BV, Camilión de Hurtado MC, Cingolani HE. Enalapril induces regression of cardiac hypertrophy and normalization of pHi regulatory mechanisms. Hypertension. 1998; 31: 961–967.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Woodiwiss AJ, Tsotetsi OJ, Sprott S, Lancaster EJ, Mela T, Chung ES, Meyer TE, Norton GR. Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation. 2001; 103: 155–160.
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
April 19, 2002, Volume 90, Issue 7
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    Na+-H+ Exchanger Inhibition
    Horacio E. Cingolani and María Cristina Camilión de Hurtado
    Circulation Research. 2002;90:751-753, originally published April 19, 2002
    https://doi.org/10.1161/01.RES.0000016836.24179.AE

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Na+-H+ Exchanger Inhibition
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    Na+-H+ Exchanger Inhibition
    Horacio E. Cingolani and María Cristina Camilión de Hurtado
    Circulation Research. 2002;90:751-753, originally published April 19, 2002
    https://doi.org/10.1161/01.RES.0000016836.24179.AE
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Heart Failure and Cardiac Disease
    • Heart Failure
  • Intervention, Surgery, Transplantation
    • Pharmacology
  • Genetics
    • Gene Expression & Regulation
  • Basic, Translational, and Clinical Research
    • Animal Models of Human Disease

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured